Results 71 to 80 of about 17,249 (148)
C3 deposits worsens the prognosis in type iii extracapillary glomerulonephritis
Introduction: Type iii extracapillary glomerulonephritis (PEGN) is a common cause of rapidly progressive glomerulonephritis and it is usually associated with circulating anti-neutrophil cytoplasmic antibodies (ANCAs). Recent evidence points to complement
Marina Sánchez-Agesta Martínez +6 more
doaj +1 more source
Immunotactoid glomerulonephritis (ITGN) is characterized by organized deposits in the form of microtubules on electron microscopy that stain for monoclonal or polyclonal immunoglobulins (Igs) along with complements.
Gnanapriya Vellaisamy +4 more
doaj +1 more source
Background: All types of membranoproliferative glomerulonephritis (MPGN) are progressive diseases with poor prognoses. Recently, a newly proposed classification of these diseases separated them into immune complex- and complement-mediated diseases.
Sung Ae Woo +9 more
doaj +1 more source
Journal of Hospital Medicine, Volume 21, Issue 2, Page 200-204, February 2026.
Gurpreet Dhaliwal +4 more
wiley +1 more source
A rare co-existence of celiac disease and C3 glomerulopathy
Glomerulonephritis associated with celiac disease (CD) is rarely reported. Here we report a rare case of nephrotic syndrome associated with C3 glomerulopathy (C3G) in a patient with CD. A 19-year-old female with bilateral leg swelling and hypoalbuminemia
Ali Ilter +3 more
doaj +1 more source
Immunoelectron microscopy findings in a patient with C3 glomerulonephritis. [PDF]
Sawamura M +16 more
europepmc +1 more source
C3 Glomerulonephritis Presenting With Nephritic and Nephrotic Syndromes: Spontaneous Remission After Six Months on Dialysis. [PDF]
Gonçalves F +4 more
europepmc +1 more source
Post-streptococcal glomerulonephritis is an immune complex-mediated glomerulonephritis as a result of transient dysregulation of alternate complement pathway along with in situ immune complex formation.
Shashank M. Shivanna +4 more
doaj +1 more source
Pembrolizumab induced-C3 glomerulonephritis and RBC cast nephropathy: a case report. [PDF]
Yang Z, Xu H, Gou S, Wu H, Hu Z.
europepmc +1 more source
Eculizumab in C3 Glomerulopathy: A Systematic Review of Therapeutic Efficacy and Clinical Outcomes
Background: C3 glomerulopathies (C3G), including dense deposit disease (DDD) and C3 glomerulonephritis (C3GN), are rare kidney disorders driven by dysregulation of the alternative complement pathway.
Dominik Lewandowski +6 more
doaj +1 more source

